-
BARRIERS AND FACILITATORS IMPACT PERSISTENCE OF SGLT2 INHIBITORS & GLP-1 RECEPTOR AGONISTS FOR TYPE 2 DIABETES: A QUALITATIVE STUDY WITH HEALTHCARE PROVIDERS
Mar 18, 2026, 21:38 PM -
RECENT TRENDS IN ON-DEMAND TREATMENT PRESCRIPTIONS FOR HEREDITARY ANGIOEDEMA: A US CLAIMS DATABASE ANALYSIS
Mar 18, 2026, 21:38 PM -
HEALTH UTILITY SCORES ACROSS MAJOR CANCER TYPES BY STAGE AND TREATMENT PHASE
Mar 18, 2026, 21:38 PM -
INCORPORATING ENVIRONMENTAL IMPACT INTO HEALTH TECHNOLOGY ASSESSMENT: A CASE STUDY IN INHALERS
Mar 18, 2026, 21:38 PM -
FAST, ACCURATE, RELIABLE: PROSPECTIVE FOLLOW-UP ASSESSMENT OF THE SUPERDEDUPER MODULE IN LASER AI
Mar 18, 2026, 21:38 PM -
PEMBROLIZUMAB ALONE VERSUS CHEMO-IMMUNOTHERAPY IN METASTATIC NSCLC: A 2024 MEDICARE-BASED MARKOV COST-EFFECTIVENESS ANALYSIS
Mar 18, 2026, 21:38 PM -
ZERO-SHOT LUNG CANCER RISK PREDICTION?FROM?LONGITUDINAL?ELECTRONIC?HEALTH RECORDS?WITH CHAIN-OF-AGENTS?FRAMEWORK
Mar 18, 2026, 21:38 PM -
INTEGRATING MEDICINES AND MEDICAL SERVICES IN REAL-WORLD VALUE ASSESSMENT: EVIDENCE FROM SUBCUTANEOUS ONCOLOGY FORMULATIONS IN A DAY CARE SETTING
Mar 18, 2026, 21:38 PM -
REAL WORLD EVIDENCE METHODOLOGY FOR ECONOMIC EVALUATION OF CLINICAL AI: COST EFFECTIVENESS OF AN IMAGING ALGORITHM FOR INCIDENTAL DETECTION OF HEART FAILURE WITH PRESERVED EJECTION FRACTION
Mar 18, 2026, 21:38 PM -
HEALTHCARE REIMAGINED: THE VA’S WHOLE HEALTH REVOLUTION AS A BLUEPRINT FOR A PURPOSE-DRIVEN PARADIGM SHIFT IN HEALTHCARE
Mar 18, 2026, 21:38 PM -
LONG-TERM PROPHYLACTIC TREATMENT WITH ORAL DEUCRICTIBANT IMPROVED DISEASE CONTROL AND HEALTH-RELATED QUALITY OF LIFE IN PARTICIPANTS WITH HEREDITARY ANGIOEDEMA: FINAL RESULTS OF THE CHAPTER-1 OPEN-LABEL EXTENSION STUDY
Mar 18, 2026, 21:38 PM -
CLINICAL OUTCOMES AND HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS RECEIVING EXTRACORPOREAL MEMBRANE OXYGENATION IN HUNAN PROVINCE, 2021-2024: A RETROSPECTIVE STUDY
Mar 18, 2026, 21:38 PM -
APALUTAMIDE (APA) AS FIRST OPTION TO METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) REPRESENTS COST-EFFECTIVE TREATMENT SEQUENCES TO HEALTH SYSTEMS
Mar 18, 2026, 21:38 PM -
CORTICOSTEROID AND BIOLOGIC USE IN A REAL-WORLD POPULATION WITH GENERALIZED MYASTHENIA GRAVIS IN THE UNITED STATES AND GERMANY
Mar 18, 2026, 21:38 PM -
PARENTAL BURNOUT AMONG MOTHERS: THE ROLE OF COPING STYLES AND PSYCHOLOGICAL FACTORS
Mar 18, 2026, 21:38 PM -
FROM DELAYS TO DETERIORATION: A REVIEW OF THE IMPACT OF PRIOR AUTHORIZATION ON PATIENT HEALTH
Mar 18, 2026, 21:38 PM -
VALUE OF INFORMATION ANALYSIS FOR MANAGEMENT FOR INTERMITTENT CLAUDICATION: LLM-BASED RESULTS
Mar 18, 2026, 21:38 PM -
PSYCHOMETRIC EVALUATION OF SKINDEX-16 AA, THE ALOPECIA AREATA SYMPTOM IMPACT SCALE (AASIS), AND THE SCALP HAIR ASSESSMENT PATIENT-REPORTED OUTCOME (PRO) IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA
Mar 18, 2026, 21:38 PM -
EVALUATING EARLY TREATMENT INITIATION REGIMES IN TREATMENT-RESISTANT DEPRESSION: A REINFORCEMENT LEARNING-BASED OFF-POLICY EVALUATION APPROACH
Mar 18, 2026, 21:38 PM -
?ECONOMIC IMPACT OF PET-18FLUTEMETAMOL GUIDED TREATMENT ALLOCATION IN THE DIAGNOSIS AND MANAGEMENT OF ALZHEIMER DISEASE. A BUDGET IMPACT MODEL FOR EUROPEAN PAYERS...
Mar 18, 2026, 21:38 PM
